Venkat Ramanan joins Anthos with over 20 years of financial leadership experience in the pharmaceutical industry. Most recently, he served as CFO of Turnstone Biologics, where he led the company’s transition from a private to a public company and built a best-in-class finance team. Before Turnstone, Dr. Ramanan led financial planning and analysis at Seagen during a critical period of transformation that included product launches, global footprint expansion and multiple strategic transactions. He has also held positions of increasing responsibility in finance, supply chain planning and commercial operations at Gilead Sciences and Amgen; he began his career in the biopharmaceutical industry as a consultant with ZS Associates.
Venkat holds a Ph.D. and M.S. in Engineering Mechanics from the Ohio State University and a B.S. in Mechanical Engineering from the Indian Institute of Technology.